ClassID:

96736

C07K7/06 - page 11 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids

Recent Application in this class:
#3001
20160075737
2016-03-17

Synthetic anti-inflammatory peptides and use thereof

#3002
20160075734
2016-03-17

Peptoid affinity ligands

#3003
20160074461
2016-03-17

LLP2A-bisphosphonate conjugates for osteoporosis treatment

#3004
20160068590
2016-03-10

POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE

#3005
20160068570
2016-03-10

Anti-tumor polypeptides and method for preparing anti-tumor drugs comprisng the same

#3006
20160068569
2016-03-10

Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics

#3007
20160068568
2016-03-10

Modulators of the SRC-kinase activity for preventing or treating metastatic cancer

#3008
20160067670
2016-03-10

Microwave-assisted peptide synthesis

#3009
20160067355
2016-03-10

Composition for delivery of genetic material

#3010
20160060679
2016-03-03

Compounds, substrates and methods related to histone deacetylases

#3011
20160060332
2016-03-03

Therapeutic DLL4 binding proteins

#3012
20160060295
2016-03-03

Biologically active peptides

#3013
20160060294
2016-03-03

Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof

#3014
20160060293
2016-03-03

Compositions and method for treating thrombosis

#3015
20160058871
2016-03-03

Self-assembling peptide and polysaccharide complexes

#3016
20160058828
2016-03-03

Methods, uses and compositions of Tie2 agonists

#3017
20160052982
2016-02-25

Methods and systems for designing and/or characterizing soluble lipidated ligand agents

#3018
20160052980
2016-02-25

CRP40 FRAGMENTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#3019
20160052969
2016-02-25

Templates for controlling synthesis of nanoparticles into discrete assemblies

#3020
20160052968
2016-02-25

BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE

#3021
20160052967
2016-02-25

Use of inhibitory peptides for the treatment of inflammatory diseases

#3022
20160051654
2016-02-25

Immunogenic epitopes for immunotherapy

#3023
20160051623
2016-02-25

Anti-angiogenic peptides and uses thereof

#3024
20160046673
2016-02-18

Modulation of structured polypeptide specificity

#3025
20160046670
2016-02-18

βsheet tapes ribbons in tissue engineering

#3026
20160046669
2016-02-18

Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide

#3027
20160046668
2016-02-18

Targeting peptides and uses thereof

#3028
20160046665
2016-02-18

Peptide Ligand with Antibody Selectivity and the Application Thereof

#3029
20160039901
2016-02-11

Inhibitors of TLR signaling by targeting TIR domain interfaces

#3030
20160039878
2016-02-11

Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof

#3031
20160039874
2016-02-11

REGULATING BACILLUS ANTHRACIS LETHAL FACTOR ACTIVITY VIA AN ACTIVATING EPITOPE REGION

#3032
20160039873
2016-02-11

Peptides with antifungal activity and methods of using the peptides

#3033
20160039872
2016-02-11

Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

#3034
20160033529
2016-02-04

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#3035
20160033528
2016-02-04

Methods for Selecting Peptides that Bind to Disease Specific Antibodies, Disease Specific Peptides and Uses Thereof

#3036
20160033478
2016-02-04

Use of GPR83 to identify pruritus-related substances

#3037
20160031952
2016-02-04

Amyloidosis-inhibiting polypeptides and their use

#3038
20160031942
2016-02-04

RHAMM binding peptides

#3039
20160031939
2016-02-04

Modification of polypeptides

#3040
20160031938
2016-02-04

Peptide selectively binding to graphitic materials and volatile organic compounds

#3041
20160031937
2016-02-04

NEURAL REGENERATION PEPTIDES AND USES THEREFOR

#3042
20160031936
2016-02-04

Triazole macrocycle systems

#3043
20160030533
2016-02-04

COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS

#3044
20160024153
2016-01-28

Stapled and stitched polypeptides and uses thereof

#3045
20160024152
2016-01-28

CD44V6-derived peptides for treating breast cancer

#3046
20160024151
2016-01-28

Selective inhibitor of angiotensin II

#3047
20160024150
2016-01-28

Epitope and its use

#3048
20160022831
2016-01-28

Peptides that Selectively Home to Heart Vasculature and Related Conjugates and Methods

#3049
20160022787
2016-01-28

MHC-I restricted epitopes containing non-natural amino acid residues

#3050
20160017002
2016-01-21

Process for preparing eptifibatide

#3051
20160016996
2016-01-21

Ang-(1-7) derivative oligopeptides and methods for using and producing the same

#3052
20160016995
2016-01-21

Tunable control of protein degradation in synthetic and endogenous bacterial systems

#3053
20160015835
2016-01-21

Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

#3054
20160011207
2016-01-14

DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS

#3055
20160011195
2016-01-14

Method of Forming Fragment Ligated Inhibitors

#3056
20160009763
2016-01-14

PEPTIDE MOLECULAR MATERIALS

#3057
20160008445
2016-01-14

KNTC2 peptides and vaccines containing the same

#3058
20160002295
2016-01-07

Methods and compositions for the treatment of bone remodeling disorders

#3059
20160000930
2016-01-07

Methods and compositions for targeting adipose cells in mammals

#3060
20160000891
2016-01-07

IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF

#3061
20160000877
2016-01-07

Compositions and methods for modulating gamma-C-cytokine activity

#3062
20150377899
2015-12-31

Molecule library constructed on the basis of backbone structure of microprotein

#3063
20150377879
2015-12-31

PEPTOIDS THAT BIND SPECIFIC ANTIGENS

#3064
20150376240
2015-12-31

Enhanced AAV-mediated gene transfer for retinal therapies

#3065
20150376236
2015-12-31

Peptidomimetics possessing photo-controlled biological activity

#3066
20150376235
2015-12-31

Peptides for the Treatment of Immune Reconstitution Inflammatory Syndrome (IRIS) and Related Diseases

#3067
20150374862
2015-12-31

Compositions and methods for detecting plectin-1 as a biomarker for cancer

#3068
20150374810
2015-12-31

TOMM34 peptides and vaccines including the same

#3069
20150369800
2015-12-24

HIGH-SENSITIVE FLUORESCENT ENERGY TRANSFER ASSAY USING FLUORESCENT AMINO ACIDS AND FLUORESENT PROTEINS

#3070
20150368480
2015-12-24

Antifouling materials

#3071
20150368301
2015-12-24

Peptide inhibitor of Nox1 NADPH oxidase

#3072
20150368300
2015-12-24

Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins

#3073
20150368299
2015-12-24

Amyloid-beta binding proteins

#3074
20150368298
2015-12-24

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

#3075
20150368297
2015-12-24

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

#3076
20150367028
2015-12-24

Amphiphilic linear peptide/peptoid and hydrogel comprising the same

#3077
20150362493
2015-12-17

Methods of determining levels of cleaved and/or intact kininogen

#3078
20150362490
2015-12-17

Protein biosensors, cross reactive sensor arrays and methods of use thereof

#3079
20150361140
2015-12-17

Mitochondria targeting peptide

#3080
20150361138
2015-12-17

KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals

#3081
20150361137
2015-12-17

Peptide inhibitors of nicotinic acetylcholine receptor

#3082
20150361136
2015-12-17

TRH binding site in human CNS

#3083
20150361135
2015-12-17

Polypeptide specifically binding to rare earth nanoparticles and use thereof

#3084
20150360146
2015-12-17

Purification of organic compounds using surrogate stationary phases on reversed phase columns

#3085
20150359843
2015-12-17

p53 activating peptides

#3086
20150359840
2015-12-17

Autophagy-inducing peptide analogs

#3087
20150355192
2015-12-10

Method for constructing a novel affinity peptide library for binding immunoglobulin G based on a protein affinity model of protein A

#3088
20150354024
2015-12-10

Methods for binding and precipitating gold using microbial-derived metallophores and their uses

#3089
20150353632
2015-12-10

Signal biomarkers

#3090
20150353612
2015-12-10

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

#3091
20150353608
2015-12-10

Antibody-binding peptide

#3092
20150353606
2015-12-10

Peptidomimetic compounds

#3093
20150353605
2015-12-10

Short bio-active peptides for promoting wound healing

#3094
20150353604
2015-12-10

Compositions for labeling nerves and methods of use

#3095
20150353603
2015-12-10

Endometriosis cell targeting peptide and uses thereof

#3096
20150353487
2015-12-10

PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)

#3097
20150352201
2015-12-10

Immunogenic WT-1 peptides and methods of use thereof

#3098
20150344523
2015-12-03

MUTANT AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#3099
20150343041
2015-12-03

CTL inducer composition

#3100
20150342852
2015-12-03

Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions

#3101
20150337356
2015-11-26

Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles

#3102
20150335702
2015-11-26

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#3103
20150329619
2015-11-19

Albumin fusion proteins

#3104
20150329595
2015-11-19

PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF SSDNA VIRUSES

#3105
20150329593
2015-11-19

Synthesis of beta-arrestin effectors

#3106
20150329592
2015-11-19

ALL GOLD FLUORESCENCE RESONANCE ENERGY TRANSFER PROBE AND USE THEREOF

#3107
20150329591
2015-11-19

Azapeptides as CD36 binding compounds

#3108
20150329488
2015-11-19

Targeting of EWS-FLI1 as anti-tumor therapy

#3109
20150323545
2015-11-12

SELECTED REACTION MONITORING ASSAYS

#3110
20150322113
2015-11-12

Anti-microbial activity of synthetic peptides

#3111
20150322112
2015-11-12

SEMA5B PEPTIDES AND VACCINES CONTAINING THE SAME

#3112
20150320848
2015-11-12

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#3113
20150320826
2015-11-12

TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK

#3114
20150320825
2015-11-12

Saposin-A derived peptides and uses thereof

#3115
20150315569
2015-11-05

METHOD FOR SCREENING A NUCLEIC ACID-PROGRAMMED SMALL MOLECULE LIBRARY

#3116
20150315555
2015-11-05

Fragment ligated inhibitors selective for the polo box domain of PLK1

#3117
20150315253
2015-11-05

Peptides and compositions for prevention of cell adhesion and methods of using same

#3118
20150315240
2015-11-05

Small cationic antimicrobial peptides

#3119
20150315239
2015-11-05

Method of inducing an immune response by administering WDRPUH epitope peptides

#3120
20150315238
2015-11-05

MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS

#3121
20150314015
2015-11-05

Vitamin receptor drug delivery conjugates for treating inflammation

#3122
20150314007
2015-11-05

LINKER-PAYLOAD MOLECULE CONJUGATES

#3123
20150313976
2015-11-05

Prion epitopes and methods of use thereof

#3124
20150307916
2015-10-29

Quinone-masked probes as labeling reagents for cell uptake measurements

#3125
20150307553
2015-10-29

Synthetic analogues of neural regeneration peptides

#3126
20150307552
2015-10-29

NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF

#3127
20150307551
2015-10-29

Cytotoxic peptides and antibody drug conjugates thereof

#3128
20150307550
2015-10-29

Peptide pharmaceuticals

#3129
20150306241
2015-10-29

COPOLYMERS FOR THE DELIVERY OF DRUGS INTO CELLS

#3130
20150306235
2015-10-29

Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same

#3131
20150306213
2015-10-29

HMGB1-derived peptides enhance immune response to antigens

#3132
20150306168
2015-10-29

Methods of protecting against apoptosis using lipopeptides

#3133
20150299700
2015-10-22

EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF

#3134
20150299298
2015-10-22

BINDING MOIETIES FOR BIOFILM REMEDIATION

#3135
20150299279
2015-10-22

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

#3136
20150299266
2015-10-22

Beta sheet tapes ribbons in tissue engineering

#3137
20150299264
2015-10-22

Inhibition of cardiac fibrosis in myocardial infarction

#3138
20150299262
2015-10-22

Cyclic peptide and pharmaceutical product containing same

#3139
20150299261
2015-10-22

Eptifibatide preparation method

#3140
20150299260
2015-10-22

Polypeptide expressed in the stratum corneum and use thereof

#3141
20150299259
2015-10-22

Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathies

#3142
20150299257
2015-10-22

Bioactive peptide complexes

#3143
20150299255
2015-10-22

COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS

#3144
20150299254
2015-10-22

Polymers, pharmaceutical compositions and methods of synthesizing the same

#3145
20150299253
2015-10-22

C4S proteoglycan specific transporter molecules

#3146
20150299252
2015-10-22

COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS

#3147
20150297669
2015-10-22

Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases

#3148
20150297578
2015-10-22

Selective targeting agents for mitochondria

#3149
20150292032
2015-10-15

TREATMENT OF CANCER BY TARGETING QUIESCENT CANCER CELLS

#3150
20150291662
2015-10-15

Modified peptide, CB receptor ligand, kit in vitro process for evaluating CB receptor bonds, uses, pharmaceutical composition for modulating CB receptor activity

#3151
20150290340
2015-10-15

Short interference RNA gene delivery system for systemic circulation

#3152
20150290339
2015-10-15

NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF

#3153
20150284445
2015-10-08

Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor

#3154
20150284433
2015-10-08

Peptides that stimulate subcutaneous adipogenesis

#3155
20150284430
2015-10-08

Application of SP peptide or derivative thereof in preparing medicines for preventing or treating asthma

#3156
20150284429
2015-10-08

Hepcidin mimetic peptides and uses thereof

#3157
20150284428
2015-10-08

Methods and agents for the treatment of cancer

#3158
20150284427
2015-10-08

Macrocyclic compounds for inhibition of inhibitors of apoptosis

#3159
20150282477
2015-10-08

Method for treating blood, blood products and organs

#3160
20150276753
2015-10-01

Molecular sensor and methods of use thereof

#3161
20150274820
2015-10-01

Stable and soluble antibodies inhibiting VEGF

#3162
20150274782
2015-10-01

Gamma-AApeptides with potent and broad-spectrum antimicrobial activity

#3163
20150274779
2015-10-01

Compositions and methods for regulating arterial tone

#3164
20150274778
2015-10-01

Mucin hypersecretion inhibitors and methods of use

#3165
20150273010
2015-10-01

HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1

#3166
20150266923
2015-09-24

JNK inhibitor molecules

#3167
20150266922
2015-09-24

DPP8 and DPP9 peptide inhibitors

#3168
20150266921
2015-09-24

Peptide for reducing the phosphate requirement and excretion from farm animals

#3169
20150265733
2015-09-24

BOMBESIN ANALOG PEPTIDE ANTAGONIST CONJUGATES

#3170
20150265689
2015-09-24

FOXM1 peptide and medicinal agent comprising the same

#3171
20150265671
2015-09-24

Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin

#3172
20150259417
2015-09-17

Anti-Glypican 3 Antibody

#3173
20150259390
2015-09-17

Peptides and compositions for prevention of cell adhesion and methods of using same

#3174
20150259385
2015-09-17

Pharmaceutical composition for cancer prevention and treatment containing peptide originated from C12orf59 protein as an active ingredient

#3175
20150259384
2015-09-17

Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

#3176
20150259380
2015-09-17

Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides

#3177
20150258203
2015-09-17

Drug delivery conjugates containing unnatural amino acids and methods for using

#3178
20150258165
2015-09-17

Methods for the treatment of X-linked hypophosphatemia and related disorders

#3179
20150257998
2015-09-17

TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same

#3180
20150253324
2015-09-10

Point of care assays to detect the status of tuberculosis infection

#3181
20150252101
2015-09-10

Methods and Compositions for Biomarkers of Fatigue, Fitness and Physical Performance Capacity

#3182
20150252087
2015-09-10

Treatment of brain injury with a neurotrophic peptide

#3183
20150252075
2015-09-10

NEUROPLASTIN DERIVED PEPTIDES

#3184
20150252074
2015-09-10

Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes

#3185
20150250848
2015-09-10

Therapy and kit for the prevention and treatment of cystic fibrosis

#3186
20150250847
2015-09-10

Peptides for suppressing inflammation

#3187
20150250699
2015-09-10

TRPV3 AGONISTS FOR THE TREATMENT OF SKIN CONDITIONS

#3188
20150246955
2015-09-03

Methods and compositions for specific modulation of MCL-1

#3189
20150246950
2015-09-03

Chimeric dystrophin-VSV-G protein to treat dystrophinopathies

#3190
20150246948
2015-09-03

Polypeptides and antibodies for treating HBV infection and related diseases

#3191
20150246946
2015-09-03

PEPTIDES AND METHODS FOR TREATING CANCER

#3192
20150246945
2015-09-03

Peptides that bind to epithelial cell adhesion molecule

#3193
20150246120
2015-09-03

MOESIN MODULATORS AND USES THEREOF

#3194
20150245997
2015-09-03

Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same

#3195
20150239940
2015-08-27

Compositions and methods for measles virus inhibition

#3196
20150239935
2015-08-27

Hydrogen bond surrogate macrocycles as modulators of Ras

#3197
20150239932
2015-08-27

Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage

#3198
20150238587
2015-08-27

WT1 antigen peptide conjugate vaccine

#3199
20150238561
2015-08-27

Compositions of GnRH related compounds and processes of preparation

#3200
20150238558
2015-08-27

IAP antagonists

#3201
20150232525
2015-08-20

Anti-tumour response to modified self-epitopes

#3202
20150232513
2015-08-20

Compositions and methods for treating hepatitis B

#3203
20150232511
2015-08-20

Method for producing a composition for treating a tooth lesion

#3204
20150232504
2015-08-20

Aldehyde capture ligation technology for synthesis of amide bonds

#3205
20150231239
2015-08-20

Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

#3206
20150231205
2015-08-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE

#3207
20150231195
2015-08-20

COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING

#3208
20150226740
2015-08-13

Method for identifying novel minor histocompatibility antigens

#3209
20150225461
2015-08-13

Crystalline and amorphous forms of a β-arrestin effector

#3210
20150225458
2015-08-13

Synthetic artificial peptides with antimicrobial effect

#3211
20150225456
2015-08-13

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

#3212
20150225455
2015-08-13

Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same

#3213
20150225454
2015-08-13

TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF

#3214
20150219657
2015-08-06

Phosphorylated Akt-specific capture agents, compositions, and methods of using and making

#3215
20150219654
2015-08-06

Intracellular organelle peptide targeted enzyme substrates

#3216
20150218569
2015-08-06

Method of introducing nucleic acid into plant cells

#3217
20150218277
2015-08-06

Inhibitors of the Epidermal Growth Factor Receptor- Heat Shock Protein 90 Binding Interaction

#3218
20150218248
2015-08-06

Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation

#3219
20150218224
2015-08-06

Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates

#3220
20150218222
2015-08-06

Medicaments

#3221
20150218217
2015-08-06

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

#3222
20150218216
2015-08-06

PSF1-derived peptide

#3223
20150218213
2015-08-06

INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX

#3224
20150218211
2015-08-06

Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

#3225
20150210759
2015-07-30

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

#3226
20150210757
2015-07-30

Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

#3227
20150203554
2015-07-23

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

#3228
20150203545
2015-07-23

METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS

#3229
20150203537
2015-07-23

INHIBITION OF GLIADIN PEPTIDES

#3230
20150203536
2015-07-23

CD31 peptides

#3231
20150202322
2015-07-23

Intestinal peptide targeting ligands

#3232
20150202249
2015-07-23

Anti-androgen peptides and uses thereof in cancer therapy

#3233
20150198606
2015-07-16

METHOD FOR ENHANCING TRANSPORT OF SEMICONDUCTOR NANOCRYSTALS ACROSS BIOLOGICAL MEMBRANES

#3234
20150196658
2015-07-16

Compounds

#3235
20150190527
2015-07-09

Bladder cancer specific ligand peptides

#3236
20150190490
2015-07-09

CDCA1 epitope peptides for Th1 cells and vaccines containing the same

#3237
20150190489
2015-07-09

KIF20A epitope peptides for TH1 cells and vaccines containing the same

#3238
20150190460
2015-07-09

OSTEOPONTIN PEPTIDE FRAGMENTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH

#3239
20150185216
2015-07-02

Systematic discovery, maturation and extension of peptide binders to proteins

#3240
20150183858
2015-07-02

Peptide-hinge-free flexible antibody-like molecule

#3241
20150183829
2015-07-02

RFamide-related peptides and methods thereof

#3242
20150183828
2015-07-02

Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof

#3243
20150183826
2015-07-02

CD44v6-derived peptides for treating metastasizing cancer

#3244
20150175993
2015-06-25

Synzymes

#3245
20150175664
2015-06-25

Therapeutic agents for reducing parathyroid hormone levels

#3246
20150175663
2015-06-25

Process for producing self-assembling peptide derivatives

#3247
20150175662
2015-06-25

Peptides and use thereof

#3248
20150175660
2015-06-25

Controlled modulation of amino acid side chain length of peptide antigens

#3249
20150175659
2015-06-25

Peptide derivatives as antibiotics

#3250
20150175658
2015-06-25

Induction of tumor immunity by variants of folate binding protein

#3251
20150174197
2015-06-25

Peptoids useful for the mineralization of apatite

#3252
20150174196
2015-06-25

Peptide-based collagen modulators for wound healing and tissue repair

#3253
20150174192
2015-06-25

Pea protein peptides with anti activity

#3254
20150166607
2015-06-18

CD44v6-derived peptides for treating pancreatic cancer

#3255
20150166605
2015-06-18

Linear peptide antibiotics

#3256
20150166604
2015-06-18

Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof

#3257
20150166603
2015-06-18

Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban

#3258
20150166602
2015-06-18

Process for the preparation of leuprolide and its pharmaceutically acceptable salts

#3259
20150158931
2015-06-11

CYSTEINE PROTEASE CAPTURING AGENTS

#3260
20150158914
2015-06-11

PEPTIDES, CONSTRUCTS AND USES THEREFOR

#3261
20150158912
2015-06-11

Treatment of IL-17 mediated disease by blocking SEFIR-SEFIR interactions

#3262
20150158911
2015-06-11

PIGMENT STRUCTURES, PIGMENT GRANULES, PIGMENT PROTEINS, AND USES THEREOF

#3263
20150158910
2015-06-11

PAR4 agonist peptides

#3264
20150157741
2015-06-11

Compound and photoacoustic imaging contrast medium containing the compound

#3265
20150152471
2015-06-04

Protease detection

#3266
20150152190
2015-06-04

Prostate-specific membrane antigen antibody drug conjugates

#3267
20150152152
2015-06-04

MUC-1 cytoplasmic domain peptides as inhibitors of cancer

#3268
20150152140
2015-06-04

Peptides derived from viral proteins for use as immunogens and dosage reactants

#3269
20150152139
2015-06-04

Peptide tyrosinase activators

#3270
20150151011
2015-06-04

Preparation of Technetium-99M Tricarbonyl Labeled Glycine Monomer or Oligomer Containing Probes That Have Biomolecules and Its Application as Imaging Complex-Composition

#3271
20150151010
2015-06-04

Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma

#3272
20150150980
2015-06-04

Methods and compositions for treating pain

#3273
20150150944
2015-06-04

Vault complexes for cytokine delivery

#3274
20150148523
2015-05-28

Gamma amino acid building blocks

#3275
20150148304
2015-05-28

Novel Peptides and Analogs for Use in the Treatment of Macrophage Activation Syndrome

#3276
20150148303
2015-05-28

Peptides effective in the treatment of conditions requiring the removal or destruction of cells

#3277
20150148302
2015-05-28

Peptide inhibitors of caspase 2 activation

#3278
20150148295
2015-05-28

Controlled-Released Peptide Formulations

#3279
20150148285
2015-05-28

Salt and protease-resistance of antimicrobial peptide and the manufacture thereof

#3280
20150147347
2015-05-28

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#3281
20150147346
2015-05-28

REPLIKIN SEQUENCES AND THEIR ANTIBODIES FOR DIAGNOSTICS, THERAPEUTICS, AND VACCINES AGAINST PRION AND NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER'S DISEASE

#3282
20150141347
2015-05-21

Murine anti-NY-ESO-1 T cell receptors

#3283
20150141345
2015-05-21

Compounds and methods for inhibiting cell death

#3284
20150141340
2015-05-21

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#3285
20150141337
2015-05-21

Manufacture of degarelix

#3286
20150141324
2015-05-21

STABLE PEPTIDE-BASED FURIN INHIBITORS

#3287
20150140060
2015-05-21

Compositions and methods for promoting wound healing and tissue regeneration

#3288
20150140046
2015-05-21

Compounds which inhibit neuronal exocytosis

#3289
20150139902
2015-05-21

PURIFICATION OF [18F] - FLUCICLATIDE

#3290
20150133630
2015-05-14

Screening method for peptide binding to target molecule in pH-dependent manner

#3291
20150133458
2015-05-14

Orally active, cell-penetrating homing peptide and methods of using same

#3292
20150133393
2015-05-14

Novel JNK Inhibitor Molecules for Treatment of Various Diseases

#3293
20150133367
2015-05-14

Alpha-helical peptidomimetic inhibitors and methods using same

#3294
20150132785
2015-05-14

Protease assay

#3295
20150132395
2015-05-14

Nanoemulsions

#3296
20150132355
2015-05-14

TDF-related compounds and analogs thereof

#3297
20150132328
2015-05-14

IMMUNOMODULATOR METALLOPEPTIDES (IMMPS) AND COMPOSITIONS CONTAINING SAME

#3298
20150132324
2015-05-14

Tubulysin compounds, methods of making and use

#3299
20150132230
2015-05-14

Protease assay

#3300
20150126710
2015-05-07

FUSION PROTEINS FORMING TRIMERS